PLK3 anticorps (C-Term)
-
- Antigène Voir toutes PLK3 Anticorps
- PLK3 (Polo-Like Kinase 3 (PLK3))
-
Épitope
- C-Term
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PLK3 est non-conjugé
-
Application
- Western Blotting (WB), Enzyme Immunoassay (EIA)
- Specificité
- This antibody reacts to PLK3.
- Purification
- Protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
- Immunogène
- This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the C-terminal region of human PLK3.
- Isotype
- Ig Fraction
- Top Product
- Discover our top product PLK3 Anticorps primaire
-
-
- Indications d'application
-
ELISA: 1/1,000. Western blotting: 1/100 - 1/500. Flow cytometry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.25 mg/mL
- Buffer
- PBS with 0.09 % (W/V) sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freezing and thawing.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
-
- Antigène
- PLK3 (Polo-Like Kinase 3 (PLK3))
- Autre désignation
- PLK3 (PLK3 Produits)
- Synonymes
- anticorps cnk, anticorps wu:fi35f10, anticorps fnk, anticorps prk, anticorps plx3, anticorps MGC89507, anticorps PLK2/3, anticorps NV15469, anticorps Plx3, anticorps CNK, anticorps FNK, anticorps PRK, anticorps Cnk, anticorps Fnk, anticorps polo-like kinase 3 (Drosophila), anticorps polo like kinase 3, anticorps polo-like kinase 3, anticorps polo-like kinase 3 S homeolog, anticorps polo-like kinase 3 L homeolog, anticorps Serine/threonine-protein kinase plk-3, anticorps plk3, anticorps PLK3, anticorps LOC100118436, anticorps plk3.S, anticorps plk3.L, anticorps Plk3, anticorps plk-3
- Sujet
- CNK, a member of the CDC5/Polo subfamily of Ser/Thr protein kinases, is involved in regulating M phase functions during the cell cycle. It may also be part of the signaling network controlling cellular adhesion. In vitro, is able to phosphorylate CDC25C and casein. This membrane-associated protein binds to the calcium/integrin-binding protein (CIB). This interaction probably occurs via the POLO-box domain. Transcripts are highly detected in placenta, lung, followed by skeletal muscle, heart, pancreas, ovaries and kidney and weakly detected in liver and brain. This protein exhibits a short half-live. In cells of hematopoietic origin, CNK is strongly and exclusively detected in terminally differentiated macrophages. Transcript expression appears to be down-regulated in primary lung tumor. Cytokine and cellular adhesion trigger CNK induction. CNK is thought to be phosphorylated as cells enter mitosis and dephosphorylated as cells exit mitosis The protein contains 2 POLO box domains.Synonyms: CNK, Cytokine-inducible serine/threonine-protein kinase, FGF-inducible kinase, FNK, PRK, Polo-like kinase 3, Proliferation-related kinase, Serine/threonine-protein kinase PLK3
- ID gène
- 1263, 9606
- UniProt
- Q9H4B4
- Pathways
- Regulation of long-term Neuronal Synaptic Plasticity
-